BACKGROUND. Follow-up information on free melanoma screening clinics i
s not readily available. OBJECTIVE AND METHODS. We studied the follow-
up, compliance, and outcome of positive screenees after a screening ca
mpaign for melanoma in the Netherlands. RESULTS. Of the 4146 participa
nts, 486 (11.7%) had a suspicious premalignant or malignant lesion war
ranting referral to his or her general physician indicating the propos
ed line of management. Participants with borderline lesions were not r
eferred. Referral of borderline cases should have resulted in a consid
erable increase of the number of positive screenees (18.1%). All posit
ive screenees but two gave permission for follow-up. Only 18 screenees
(3.7%) were lost during follow-up. Moreover, one screenee with a pres
umed basal cell carcinoma and six screenees suspicions of having a pre
malignant lesion decided not to seek medical attention despite several
reminders. The positive predictive value for melanoma was 17.2%, and
for nonmelanoma skin cancers was 42.9%. CONCLUSION. A selective referr
al policy may reduce the generated costs of melanoma screenings substa
ntially Adequate follow-up of positive screenees is mandatory in order
to determine the ultimate yield and usefulness of such campaigns. (C)
1997 by the American Society for Dermatologic Surgery, Inc.